SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as discussions revolve around its performance at the Salinas Airshow, particularly regarding the lack of a vertical takeoff demonstration. While some investors express concerns about this and the company's revenue, others remain bullish, anticipating potential catalysts like piloted VTOL flights and future defense contracts. The stock's high short interest is also fueling speculation about a potential squeeze.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community emphasizes its strong cultural ties and compares it favorably to Bitcoin. Community members are sharing links to the project's website, social media, and trading charts. The conversation highlights the crypto's longevity and continued relevance within its niche.

Reactive Network is the first parallelized interoperability execution layer, utilising a new form of smart contract we call reactive smart contracts.   Reactive smart contracts are able to react to on-chain events autonomously and execute their own user defined logic to initiate new transactions. This allows a virtually limitless number of use cases to achieve fully decentralized on-chain automation.

Reactive Network

Reactive Network is trending as the community discusses its potential for significant gains, drawing comparisons to early Bitcoin and XRP. Anticipation is building around the sunsetting of PRQ at the end of July, which some believe will unleash REACT's full potential. The community also highlights the project's active development team, low supply, and staking rewards as positive factors.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending due to speculation around a major announcement, with community members guessing at partnerships with institutions like Ripple, BlackRock, or ADP. Recent discussion points to a potential institutional partnership, MiCA compliance, and upcoming Uphold partnership details, fueling excitement for Zebec's future utility in real-time stablecoin payroll and potential exchange listings.

ProShares Trust - ProShares VIX Short-Term Futures ETF

ProShares VIX Short-Term Futures ETF

VIXY is trending as traders discuss the potential impact of a government shutdown and rising geopolitical tensions on market volatility. The community is weighing the possibility of a market pullback, noting indicators that suggest a correction may be on the horizon. Some traders believe the $SPY is a 'ponzi' scheme, while others are using VIXY to hedge their portfolios against potential downside.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending amid bullish sentiment in the crypto market, with community members actively discussing its potential to reach previous all-time highs. Recent developments, such as new wallet integrations enabling private cross-chain payments, are fueling speculation about ZEC's utility and long-term value as a privacy coin. The broader context of a possible altcoin season and increased focus on privacy solutions in crypto could be contributing to the increased attention.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as community members champion it as the 'Bitcoin of memes,' emphasizing its potential for significant growth and lasting relevance within the crypto space. Discussions highlight its strong narrative, linking it to the legacy of Satoshi Nakamoto and the broader crypto ethos. The community is actively promoting the idea that owning $SATOSHI is akin to honoring the foundation of the entire crypto industry.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as discussions revolve around its potential, the upcoming Caffeine AI launch, and integration with Solana. While some community members express frustration with its price performance and question its adoption, others highlight its unique technology and long-term potential. Staking rewards and the possibility of significant growth in the future are also key talking points.

Ethereum Classic

Ethereum Classic is trending as the community debates its potential, especially in relation to Ethereum's performance, with some anticipating a significant upward move while others express frustration over its current price. Many traders are closely watching key price levels and expressing long-term bullish sentiment despite recent sideways price action. The coin's proof-of-work mechanism and potential as a store of value are also being discussed.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

Linea is trending as the community discusses its potential partnership with SWIFT, viewing it as a strong validation of blockchain technology within traditional finance. Some community members are suggesting Linea could be a key player in the future of finance, while others highlight potential risks such as token unlocks and network performance issues.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Quoin Pharmaceuticals saw increased retail chatter on Wednesday after the company announced positive initial clinical data from its ongoing investigational new drug Pediatric Peeling Skin Syndrome (PSS) study evaluating QRX003.Twelve weeks of treatment produced a clear improvement in the patient's skin condition compared to initial baseline measurements.&nbsp;The stock closed at $7.65 on Wednesday, rising 20.3% during the day, but slipped 8% to $7.04 in after-hours trading.Clinical endpoints such as The Investigator's Global Assessment (IGA), Modified Ichthyosis Area Severity Index (M-IASI), and Children's Dermatology Life Quality Index (CDLQI) showed positive changes.&nbsp;The patient's IGA score changed from severe to mild, M-IASI decreased from 36 to 12, and CDLQI, the quality of life measure, fell from 19 to 11. The study reported no adverse events while administering QRX003 to patients.Quoin will extend the patient's treatment while performing additional clinical evaluations after 24 weeks of therapy.&nbsp;The firm continues to progress QRX003 through late-stage clinical trials targeting Netherton Syndrome, another uncommon skin condition.Peeling Skin Syndrome is a rare genetic disorder that manifests through excessive outer skin shedding, leading to persistent pain and itching.&nbsp;Without any existing approved treatments, the promising results from QRX003 trials suggest its potential importance if future studies confirm the positive outcomes.CEO Michael Myers stressed the clinical importance of observed improvements and pointed out QRX003's potential to become the first approved therapy for PSS, noting plans to expand the study internationally.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 2,314% surge in 24-hour message volume.One user noted that some investors with less conviction tend to sell just before market close, expressing hope that the stock would open at $20.&nbsp;<stembedurl>https://stocktwits.com/89gt/message/614698425</stembedurl>Another user highlighted the stock’s potential for rapid movement due to its very low float and recent positive news.<stembedurl>https://stocktwits.com/MasterofThePennies/message/614637863</stembedurl>The stock has declined 67.5% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail Buzz Intensifies Around Quoin Pharma Stock After Positive Pediatric Skin Study Data

The stock closed up 20% on Wednesday, driven by promising patient outcomes and no reported adverse events for its Pediatric Peeling Skin Syndrome (PSS) drug, with further treatment and evaluations planned.

Equity

Maxim Group Sticks to Their Buy Rating for Quoin Pharmaceuticals (QNRX)

Maxim Group analyst Naz Rahman reiterated a Buy rating on Quoin Pharmaceuticals (QNRX Research Report) yesterday. The company's shares opened tod...

Q4 2023 Quoin Pharmaceuticals Ltd Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical...

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a clinical stage specialty pharmaceutical company focused on rare and orphan...

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers...

Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering

ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a specialty pharmaceutical company focused on rare and orphan diseases, today...

Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers

Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers...

12 titoli sanitari in movimento, pre-market del 04/03/2024

Titoli in rialzo
Il titolo Quoin Pharmaceuticals (NASDAQ:QNRX) salito del 129,59% a 6,36 dollari durante la sessione pre-market di luned .
Le azioni di Renalytix (NASDAQ:RNLX) hanno guadagnato il...

12 acciones de salud en movimiento durante la preapertura del 04/03/2024

Acciones al alza
Quoin Pharmaceuticals (NASDAQ:QNRX) crecieron un 129,95% para establecerse en los 6,37 d lares durante la sesi n del pre-market del lunes.
Ainos (NASDAQ:AIMD) experimentaron un...

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

QNRX
Quoin Pharmaceuticals Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest QNRX News

QNRX Quoin Pharmaceuticals Ltd - ADR